Breaking News Instant updates and real-time market news.

DLX

Deluxe

$40.53

-0.29 (-0.71%)

, GFF

Griffon

$16.40

(0.00%)

10:59
07/09/19
07/09
10:59
07/09/19
10:59

CJS Securities to hold a conference

19th Annual New Ideas Summer Conference 2019 will be held in Greenwich, CT on July 9.

DLX

Deluxe

$40.53

-0.29 (-0.71%)

GFF

Griffon

$16.40

(0.00%)

HI

Hillenbrand

$39.22

-0.28 (-0.71%)

IVC

Invacare

$4.86

-0.25 (-4.89%)

NOVT

Novanta

$92.01

0.94 (1.03%)

OEC

Orion Engineered

$19.69

-0.3 (-1.50%)

SKY

Skyline

$26.66

-0.07 (-0.26%)

  • 25

    Jul

  • 30

    Jul

  • 14

    Aug

  • 15

    Aug

  • 27

    Aug

  • 28

    Aug

  • 09

    Sep

  • 25

    Sep

  • 13

    Nov

DLX Deluxe
$40.53

-0.29 (-0.71%)

10/12/18
BUCK
10/12/18
INITIATION
BUCK
Neutral
Deluxe initiated with a Neutral at Buckingham
GFF Griffon
$16.40

(0.00%)

10/02/18
GSCO
10/02/18
INITIATION
Target $18
GSCO
Neutral
Griffon initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Doug Clark started Griffon with a Neutral rating and $18 price target. The analyst rolled out coverage on the Building Products sector with Neutral rating.
10/02/18
GSCO
10/02/18
INITIATION
Target $18
GSCO
Neutral
Griffon initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Doug Clark initiated Griffon with a Neutral and $18 price target.
10/30/18
JPMS
10/30/18
INITIATION
Target $11
JPMS
Underweight
Griffon initiated with an Underweight at JPMorgan
JPMorgan analyst Michael Rehaut started Griffon with an Underweight rating and $11 price target. The analyst sees the company's "solidly below average" sales growth and EBITDA margins, and "significantly elevated" leverage level, as "relative negatives" against the broader building products universe. Further, he believes Griffon's margin upside is fairly limited near term.
11/23/18
DBAB
11/23/18
NO CHANGE
Target $13
DBAB
Hold
Griffon price target lowered to $13 from $18 at Deutsche Bank
Deutsche Bank analyst Nishu Sood lowered his price target for Griffon to $13 saying tariffs and input costs are slowing the company's margin expansion. However, Griffon's low new residential housing exposure should help if housing stalls, says the analyst. He keeps a Hold rating on the shares.
HI Hillenbrand
$39.22

-0.28 (-0.71%)

05/21/19
05/21/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Uber (UBER) initiated with an Equal Weight at Consumer Edge and a Neutral at Susquehanna. 2. Incyte (INCY) initiated with a Neutral at Credit Suisse. 3. Hillenbrand (HI) initiated with a Neutral at DA Davidson. 4. Target Hospitality (TH) initiated with a Buy at Deutsche Bank. 5. Jack in the Box (JACK) reinstated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/21/19
05/21/19
INITIATION
Target $43

Neutral
Hillenbrand initiated with a Neutral at DA Davidson
As previously reported, DA Davidson analyst Matt Summerville initiated Hillenbrand with a Neutral rating and a price target of $43. The analyst notes that the all-time record backlog in the company's Process Equipment Group segment supports its mid-single-digit organic growth, with "large plastics projects" as well as high win rates and share gains, but sees its Batesville segment facing "long-term secular challenges" with volume erosion driven margin pressure. While Summerville remains positive on Hillenbrand's "healthy" balance sheet and M&A appetite, he warns that the company's Batesville segment may see low-single-digit organic sales decline in each year of his outlook.
05/20/19
DADA
05/20/19
INITIATION
Target $43
DADA
Neutral
Hillenbrand initiated with a Neutral at DA Davidson
DA Davidson initiated Hillenbrand with a Neutral and $43 price target.
05/16/19
05/16/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jefferies starts 'underappreciated' Par Technology (PAR) with Buy rating. 2. Ichor Holdings (ICHR) initiated with a Buy at B. Riley FBR. 3. T2 Biosystems (TTOO) initiated with a Buy at Alliance Global Partners. 4. CV Sciences (CVSI) initiated with a Buy at Roth Capital. 5. Hillenbrand (HI) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
IVC Invacare
$4.86

-0.25 (-4.89%)

08/15/18
KEYB
08/15/18
DOWNGRADE
KEYB
Sector Weight
Invacare downgraded to Sector Weight from Overweight at KeyBanc
08/16/18
08/16/18
DOWNGRADE

Sector Weight
Invacare downgraded to Sector Weight after Q2 results at KeyBanc
As previously reported, KeyBanc analyst Matthew Mishan downgraded Invacare to Sector Weight from Overweight post Q2. The analyst believes its turnaround is not progressing as quickly as he hoped and rather than seeing some acceleration toward long-term targets, Mishan is again resetting his expectations lower. While stable with some positives, there are still headwinds constraining broader sales momentum, the analyst notes, adding that he is surprised there has not been more upside to margins given both restructuring activity and mix shift.
01/24/19
NEED
01/24/19
INITIATION
Target $15
NEED
Buy
Invacare initiated with a Buy at Needham
Needham analyst Mike Matson initiated Invacare with a Buy rating and a price target of $15, saying the company's global business is "growing and profitable", even though North America operations have suffered from "myriad of challenges". The analyst believes that the stock is trading as a "distressed asset due to its recent history of declining revenue and negative margins", but contends that over 80% of the company is "healthy", expecting its management to "stabilize its revenue, margins, and cash flow".
NOVT Novanta
$92.01

0.94 (1.03%)

07/31/18
WBLR
07/31/18
NO CHANGE
WBLR
Outperform
Novanta selloff today brings buying opportunity, says William Blair
William Blair analyst Brian Drab recommends using today's weakness in shares of Novanta (NOVT) following IPG Photonics' (IPGP) results as a buying opportunity. The analyst recommends take advantage of the volatility in the laser market. He keeps an Outperform rating on Novanta.
01/04/19
STFL
01/04/19
NO CHANGE
Target $45
STFL
Buy
IntriCon selling pressure overdone, says Stifel
Stifel analyst Jonathan Block said IntriCon (IIN) remains one of his highest conviction ideas and he contends that the stock seems oversold at current levels. After "a wild ride in 2018," the stock is trading at a discount to other value added suppliers even after zeroing out any valuation at all for Hearing, noted Block, who said this is despite IntriCon possessing a greater top-line growth profile and superior long-term margin structure than Medical peers such as Integer (ITGR) and Novanta (NOVT). Block keeps a Buy rating on IntriCon shares, though he lowered his price target on the stock to $45 from $70.
OEC Orion Engineered
$19.69

-0.3 (-1.50%)

03/11/19
JPMS
03/11/19
DOWNGRADE
Target $20
JPMS
Neutral
JPMorgan downgrades Orion Engineered to Neutral, prefers peer Cabot
JPMorgan analyst Jeffrey Zekauskas downgraded Orion Engineered Carbons (OEC) to Neutral from Overweight and lowered his price target for the shares to $20 from $31 following the company's Q4 results. Orion's peer company Cabot (CBT) offers a comparable but lower valuation and stronger business prospects, Zekauskas tells investors in a research note. Cabot has about 50% more carbon black pounds per share than Orion, in a rising environment for carbon black prices, says the analyst.
03/11/19
JPMS
03/11/19
DOWNGRADE
Target $20
JPMS
Neutral
Orion Engineered downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Orion Engineered Carbons to Neutral and lowered his price target for the shares to $20 from $31.
03/07/19
03/07/19
NO CHANGE

Orion Engineered reports Q4 adjusted EPS 48c, consensus 47c
Reports Q4 revenue $386.0M, consensus $373.83M. Q4 adjusted EBITDA decreased by $1.5M to $64.4M. Reports Q4 volume 256.2kmt, down 6.1% from last year.
12/21/18
JEFF
12/21/18
NO CHANGE
Target $37
JEFF
Buy
Orion Engineered likely one of first smid stocks to 'snap back,' says Jefferies
Jefferies analyst Laurence Alexander says Orion Engineered Carbons will likely be one of the first smid-caps under his coverage to "snap back sharply." Tight supply/demand carbon black balances and competitor discipline suggest the pricing cycle could extend into the next decade, Alexander tells investors in a research note. Further, he believes mix upgrades will likely continue and that lower oil prices should bolster the company's free cash flow in the near-term. The analyst lowered his price target for Orion Engineered to $37 from $41 and keeps a Buy rating on the shares.
SKY Skyline
$26.66

-0.07 (-0.26%)

11/29/18
11/29/18
INITIATION

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pluralsight (PS) initiated with an Outperform at Baird. 2. Expedia (EXPE) initiated with a Market Perform at Telsey Advisory. 3. Energy Transfer LP (ET) initiated with a Buy at Citi. 4. Skyline (SKY) initiated with a Neutral at Credit Suisse. 5. CBS (CBS) and Viacom (VIAB, VIA) were reinstated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/19
RHCO
01/31/19
UPGRADE
RHCO
Buy
Skyline upgraded to Buy from Hold at SunTrust
01/31/19
01/31/19
UPGRADE
Target $22

Buy
Skyline upgraded to Buy from Hold at SunTrust
As previously reported, SunTrust analyst Rohit Seth upgraded Skyline to Buy but lowered his price target to $22 from $30. The analyst attributes the rating to change to valuation, saying the multiple on the stock has been cut in half since September because of a confluence of factors, but he expects these drivers to fade after next week's earnings. Seth sees the company as "one of the most attractive growth stories at a reasonable price in the building product universe" with leverage to "early-cycle industry with an emerging structural driver that could double earnings in 5 years".
02/07/19
CHLM
02/07/19
NO CHANGE
Target $30
CHLM
Buy
Skyline price target lowered to $30 from $37 at Craig-Hallum
Craig-Hallum analyst Greg Palm lowered his price target for Skyline to $30 from $37, while reiterating a Buy rating on the shares. The analyst notes that quarterly results were solidly ahead of expectations. While the order environment has moderated somewhat in recent months, Palm believes that most of the softness can be attributed to normal seasonality and weather-related impacts and notes Skyline's very little exposure to low price point units in Texas, where some of the weaker demand trends have occurred lately.

TODAY'S FREE FLY STORIES

FB

Facebook

$202.32

3.94 (1.99%)

07:35
07/23/19
07/23
07:35
07/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ARAY

Accuray

$3.91

-0.07 (-1.76%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
CNNC Accuray Medical Technology receives safety license in China »

Accuray provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
Cytokinetics granted European orphan designation for reldesemtiv »

Cytokinetics Incorporated…

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Hot Stocks
Kimberly-Clark CEO says 'we made excellent progress in the second quarter' »

CEO Mike Hsu said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LECO

Lincoln Electric

$85.18

0.39 (0.46%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lincoln Electric reports Q2 adjusted EPS $1.28, consensus $1.27 »

Reports Q2 revenue $777M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lockheed Martin raises FY19 EPS view to $20.85-$21.15 from $20.05-$20.35 »

Consensus is $20.57.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

INGR

Ingredion

$80.40

-0.705 (-0.87%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 22

    Aug

  • 19

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Kimberly-Clark raises FY19 adj. EPS view to $6.65-$6.80 from $6.50-$6.70 »

FY19 consensus $6.72. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SEDG

SolarEdge

$63.08

-0.2 (-0.32%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Recommendations
SolarEdge analyst commentary at Canaccord »

SolarEdge price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Earnings
Lockheed Martin reports Q2 EPS $5.00, consensus $4.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Earnings
Kimberly-Clark reports Q2 adjusted EPS $1.67, consensus $1.61 »

Reports Q2 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

T

AT&T

$32.14

-0.63 (-1.92%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

WDDMF

WeedMD

$0.00

(0.00%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Hot Stocks
WeedMD launches cannabis extraction affiliate CX Industries »

WeedMD announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated at BTIG »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary at Credit Suisse »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary at H.C. Wainwright »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$147.16

1.98 (1.36%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Hershey analyst commentary at Wells Fargo »

Hershey price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

INAP

Internap

$2.76

-0.23 (-7.69%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Hot Stocks
Internap launches Intelligent Monitoring managed cloud and monitoring service »

Internap Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$105.16

1.14 (1.10%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Initiation
Silicon Labs initiated at Benchmark »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Downgrade
Viveve rating change at Mizuho »

Mizuho double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.64

-0.25 (-0.46%)

07:20
07/23/19
07/23
07:20
07/23/19
07:20
Recommendations
Mondelez analyst commentary at Wells Fargo »

Mondelez price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.